These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 22939337)

  • 21. Plasmid DNA-loaded chitosan/TPP nanoparticles for topical gene delivery.
    Özbaş-Turan S; Akbuğa J
    Drug Deliv; 2011 Apr; 18(3):215-22. PubMed ID: 21226549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
    Lin CC; Lin CW
    Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymeric nanoparticles for topical delivery of alpha and beta arbutin: preparation and characterization.
    Ayumi NS; Sahudin S; Hussain Z; Hussain M; Samah NHA
    Drug Deliv Transl Res; 2019 Apr; 9(2):482-496. PubMed ID: 29569027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
    Shinde UA; Joshi PN; Jain DD; Singh K
    Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
    Makhlof A; Tozuka Y; Takeuchi H
    Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin.
    Maestrelli F; Garcia-Fuentes M; Mura P; Alonso MJ
    Eur J Pharm Biopharm; 2006 Jun; 63(2):79-86. PubMed ID: 16527473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation, characterization and in vitro release study of carvacrol-loaded chitosan nanoparticles.
    Keawchaoon L; Yoksan R
    Colloids Surf B Biointerfaces; 2011 May; 84(1):163-71. PubMed ID: 21296562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules.
    Teijeiro-Osorio D; Remuñán-López C; Alonso MJ
    Biomacromolecules; 2009 Feb; 10(2):243-9. PubMed ID: 19117404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of β-cyclodextrin modified chitosan-poly(acrylic acid) nanoparticles and use as drug carriers.
    Wang X; Chen C; Huo D; Qian H; Ding Y; Hu Y; Jiang X
    Carbohydr Polym; 2012 Sep; 90(1):361-9. PubMed ID: 24751053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation.
    Shahbazi MA; Hamidi M; Mohammadi-Samani S
    J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization of chitosan/β-cyclodextrin nanoparticles containing plasmid DNA encoding interleukin-12.
    Nahaei M; Valizadeh H; Baradaran B; Nahaei MR; Asgari D; Hallaj-Nezhadi S; Dastmalchi S; Lotfipour F
    Drug Res (Stuttg); 2013 Jan; 63(1):7-12. PubMed ID: 23447042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
    Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
    Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol.
    Deng F; Hu W; Chen H; Tang Y; Zhang L
    Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
    Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
    Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine.
    Mishra D; Jain N; Rajoriya V; Jain AK
    J Pharm Pharmacol; 2014 Aug; 66(8):1082-93. PubMed ID: 24641311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.
    Gan Q; Wang T
    Colloids Surf B Biointerfaces; 2007 Sep; 59(1):24-34. PubMed ID: 17555948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimuli-sensitive hollow spheres from chitosan-graft-β-cyclodextrin for controlled drug release.
    Yu N; Li G; Gao Y; Liu X; Ma S
    Int J Biol Macromol; 2016 Dec; 93(Pt A):971-977. PubMed ID: 27663551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
    Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
    Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel chitosan-citric acid crosslinked beta-cyclodextrin nanocarriers for insoluble drug delivery.
    Karpkird T; Manaprasertsak A; Penkitti A; Sinthuvanich C; Singchuwong T; Leepasert T
    Carbohydr Res; 2020 Dec; 498():108184. PubMed ID: 33189031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.